Submission of Intimation of Closure of Trading Window.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd has informed BSE that the trading window for dealing in its securities will be closed for designated persons, their relatives, and other insiders starting January 1, 2026. The closure will remain in effect until 48 hours after the company declares its unaudited financial results for the quarter ending December 31, 2025. The exact board meeting date for considering these results will be communicated separately. The filing is a routine compliance requirement under SEBI's Insider Trading Regulations, 2015, and was signed by Whole-time Director Venkateshwarlu Pulluru on December 31, 2025.
This is a standard regulatory intimation with no direct impact on shareholders or the stock price. It simply restricts insiders from trading in the company's stock ahead of the upcoming quarterly results announcement.